1. Glioma targeted therapy: insight into future of molecular approaches
   Keyang Yang et al, 2022, Molecular Cancer CrossRef
2. Parkinsonian Patients Requiring Proteasome Inhibitors for Multiple Myeloma: Exceptional Circumstances Call for Extra Caution
   Pierre Rocanières et al, 2022, Journal of Parkinson's Disease CrossRef
3. The Future Glioblastoma Clinical Trials Landscape: Early Phase 0, Window of Opportunity, and Adaptive Phase I–III Studies
   Nicholas S. Cho et al, 2023, Current Oncology Reports CrossRef
4. Brain-Permeable Immunoproteasome-Targeting Macrocyclic Peptide Epoxyketones for Alzheimer’s Disease
   Ji Eun Park et al, 2024, Journal of Medicinal Chemistry CrossRef
5. Molecular targeted therapy: A new avenue in glioblastoma treatment (Review)
   Oula El Atat et al, 2022, Oncology Letters CrossRef
6. The NF-κB Pharmacopeia: Novel Strategies to Subdue an Intractable Target
   Daniela Verzella et al, 2022, Biomedicines CrossRef
7. Investigational new drugs against glioblastoma
   David Olayinka Kamson et al, 2021, Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies CrossRef
8. Drug Repurposing, a Fast-Track Approach to Develop Effective Treatments for Glioblastoma
   Ioannis Ntafoulis et al, 2022, Cancers CrossRef
9. An insight into the ubiquitin-proteasomal axis and related therapeutic approaches towards central nervous system malignancies
   Pritam Kumar Roy et al, 2022, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef